What question did this study set out to answer?

Evaluate the long-term safety and efficacy of taTME in treating mid and low rectal tumors.

March 5, 2026Annals of Surgery0 citations

Long-Term Results of the North American Phase II taTME Multicenter Trial for Rectal Cancer

KDKatherine F. DonovanMount Sinai Hospital HCHeather CarmichaelPenn State Milton S. Hershey Medical Center SCSami A. ChadiUniversity Health Network

Key Points

Evaluate the long-term safety and efficacy of taTME in treating mid and low rectal tumors.
Conducted a Phase II multicenter trial
Assessed three-year outcomes after taTME
Compared results with contemporary studies
Outcomes support the safety of taTME for resectable tumors
Efficacy outcomes are similar to other studies
Need for longer-term oncologic and functional outcomes is highlighted

Abstract

Three-year outcomes of this multicenter trial support the safety and efficacy of taTME in resectable mid and low rectal tumors, with outcomes comparable to contemporary studies. Longer term oncologic and functional outcomes are needed.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Donovan et al. (Tue,) studied this question.

synapsesocial.com/papers/69a91d7cd6127c7a504c0461 https://doi.org/https://doi.org/10.1097/sla.0000000000007044

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper